$0.5166
-0.11-18.00%
al cierre: -
$0.4952
-0.02-4.14%
After hour: Oct 31, 7:55 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Harvard Bioscience informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$0.010
Estimación de ingresos trimestrales
$20.00M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$88.75M
Analice el historial de beneficios de Harvard Bioscience utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HBIO | Harvard Bioscience | -$0.02 | $0.01 | — | — | $21.97M | $20.00M | — | — | 11/06/2025 | |
HBIO | Harvard Bioscience | $0.00 | -$0.02 | -$0.01 | 50.00% | $23.10M | $18.75M | $20.45M | 9.07% | 08/11/2025 | |
HBIO | Harvard Bioscience | $0.02 | -$0.04 | -$0.01 | 75.00% | $24.51M | $19.20M | $21.77M | 13.41% | 05/12/2025 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.06 | 20.00% | $28.15M | $24.15M | $24.56M | 1.68% | 03/12/2025 | |
HBIO | Harvard Bioscience | $0.01 | $0.03 | -$0.02 | -166.67% | $25.36M | $25.30M | $21.97M | -13.16% | 11/07/2024 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.00 | -100.00% | $28.76M | $26.40M | $23.10M | -12.51% | 08/08/2024 | |
HBIO | Harvard Bioscience | $0.06 | $0.02 | $0.02 | 0.00% | $29.98M | $25.79M | $24.51M | -4.96% | 05/07/2024 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.04 | -20.00% | $28.43M | $29.11M | $28.15M | -3.29% | 03/07/2024 | |
HBIO | Harvard Bioscience | -$0.01 | $0.04 | $0.01 | -75.00% | $26.92M | $28.02M | $25.36M | -9.48% | 11/07/2023 | |
HBIO | Harvard Bioscience | $0.05 | $0.05 | $0.04 | -20.00% | $29.21M | $29.50M | $28.76M | -2.51% | 08/08/2023 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.06 | 20.00% | $28.78M | $28.85M | $29.98M | 3.90% | 04/25/2023 | |
HBIO | Harvard Bioscience | $0.08 | $0.03 | $0.04 | 33.33% | $33.05M | $30.33M | $28.43M | -6.27% | 03/09/2023 | |
HBIO | Harvard Bioscience | $0.06 | $0.07 | -$0.01 | -114.29% | $29.66M | $28.89M | $26.92M | -6.81% | 11/08/2022 | |
HBIO | Harvard Bioscience | $0.06 | $0.06 | $0.05 | -16.67% | $29.20M | $30.49M | $29.21M | -4.20% | 08/03/2022 | |
HBIO | Harvard Bioscience | $0.05 | $0.05 | $0.04 | -20.00% | $26.99M | $28.77M | $28.78M | 0.03% | 05/04/2022 | |
HBIO | Harvard Bioscience | $0.08 | $0.10 | $0.08 | -20.00% | $30.98M | $32.96M | $33.05M | 0.29% | 03/08/2022 | |
HBIO | Harvard Bioscience | $0.04 | $0.06 | $0.06 | 0.00% | $24.04M | $27.91M | $29.66M | 6.28% | 11/03/2021 | |
HBIO | Harvard Bioscience | $0.05 | $0.06 | $0.06 | 0.00% | $23.31M | $27.67M | $29.20M | 5.52% | 08/05/2021 | |
HBIO | Harvard Bioscience | -$0.01 | $0.03 | $0.05 | 66.67% | $23.77M | $25.73M | $26.99M | 4.89% | 05/06/2021 | |
HBIO | Harvard Bioscience | $0.08 | $0.06 | $0.08 | 33.33% | $30.97M | $27.13M | $30.98M | 14.21% | 03/10/2021 | |
HBIO | Harvard Bioscience | $0.04 | $0.03 | $0.04 | 33.33% | $27.42M | $24.05M | $24.04M | -0.05% | 11/05/2020 |
Harvard Bioscience (HBIO) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-0.01 | $-0.02 | 50.0 % |
| Q1 | 2025-05-12 | $-0.01 | $-0.04 | 75.0 % |
| Q4 | 2025-03-12 | $0.06 | $0.05 | 20.0 % |
| Q3 | 2024-11-07 | $-0.02 | $0.03 | -166.7 % |
Harvard Bioscience (HBIO) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $20.45M | $18.75M | 9.07 % |
| Q1 | 2025-05-12 | $21.77M | $19.20M | 13.4 % |
| Q4 | 2025-03-12 | $24.56M | $24.15M | 1.68 % |
| Q3 | 2024-11-07 | $21.97M | $25.30M | -13.2 % |
PREGUNTAS FRECUENTES
¿Cuándo Harvard Bioscience (NASDAQ:HBIO) publicará los resultados?
Está previsto que Harvard Bioscience (HBIO) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 11, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Harvard Bioscience (NASDAQ:HBIO)?
El BPA real fue de $-0.01, que superó la estimación de $-0.02.
¿Cuáles fueron los ingresos de Harvard Bioscience (NASDAQ:HBIO)?
Los ingresos reales fueron $20.4M, que superó la estimación de $18.8M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.